Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04349475

Therapeutic Omegas for Triglyceride Suppression

Pilot RCT Intervention Targeting Elevated Triglycerides With a Point-of-Care Meter and Omega-3 Fatty Acids to Normalize Triglycerides and Fetal Growth

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
0 Years – 39 Years
Healthy volunteers
Accepted

Summary

This study plans to learn more about how an omega-3 fatty acid supplement effects triglyceride levels in pregnancy. Triglycerides are a type of fat found in your blood. Your body converts extra calories into triglycerides to be stored and used later for energy. It is normal for triglyceride levels to go up during pregnancy however some women have levels that are \~30-40% higher than normal when they reach their third trimester of pregnancy. Having high triglycerides in pregnancy may be related to an increased chance of having a baby that is large for their age. The goal of this study is to determine if taking an omega-3 fatty acid supplement can slow the rise in triglyceride levels later in pregnancy.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTIntervention Omega 3 SupplementationParticipants will supplement 4g of Omega 3 fish oil daily (750DHA/250EPA)
DIETARY_SUPPLEMENTControl Safflower OilParticipants will consume 2.5g of a Safflower oil supplement daily

Timeline

Start date
2021-11-29
Primary completion
2025-12-01
Completion
2025-12-31
First posted
2020-04-16
Last updated
2024-10-04

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04349475. Inclusion in this directory is not an endorsement.